Oklahoma City, OK, United States of America

William M Canfield

This inventor holds 13 USPTO granted patents and 1 published patent application, primarily in Lysosomal Biology. Top assignees: Genzyme Glycobiology Research Institute Inc., Genzyme Corporation, Novazyme Pharmaceuticals, Inc.. Active years: 2002-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: William M Canfield. Retrieved from https://idiyas.com/inventor/william-m-canfield

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 13 

% Patents Active = 100.0

Average Co-Inventor Count = 1.2

ph-index = 12

Forward Citations = 502(Granted Patents)


Company Filing History:


Years Active: 2002-2008

Loading Chart...
Areas of Expertise:
Lysosomal Targeting
Phosphotransferase
Hydrolase
Phosphorylated Enzymes
Storage Diseases
GlcNAc
Biochemical Pathways
Galactosyl Transferases
13 patents (USPTO):Explore Patents

Title: The Innovations of William M. Canfield

Introduction

William M. Canfield is a notable inventor based in Oklahoma City, OK (US). He has made significant contributions to the field of glycobiology, particularly in the area of lysosomal enzymes. With a total of 13 patents to his name, Canfield's work has had a profound impact on medical research and therapeutic development.

Latest Patents

Among his latest patents, Canfield has developed the GlcNAc phosphotransferase of the lysosomal targeting pathway. This invention provides nucleotide and amino sequences of the enzyme GlcNAc-phosphotransferase, along with methods for producing and purifying this enzyme. Another significant patent involves the expression of lysosomal hydrolase in cells that express pro-N-acetylglucosamine-1-phosphodiester α-N-acetyl glucosaminidase. This invention outlines methods for producing this enzyme in mammalian cells that are deficient in the furin proteolytic enzyme, as well as methods for creating lysosomal hydrolases that contain N-acetylglucosamine-1-phosphate.

Career Highlights

Canfield has worked with prominent organizations such as the Genzyme Glycobiology Research Institute Inc. and Genzyme Corporation. His work in these institutions has allowed him to advance his research and contribute to the development of innovative solutions in glycobiology.

Collaborations

Some of his notable coworkers include Stuart Kornfeld and Mariko Kudo. Their collaborative efforts have further enriched the research landscape in which Canfield operates.

Conclusion

William M. Canfield's contributions to the field of glycobiology through his patents and collaborations highlight his role as a leading inventor. His work continues to influence advancements in medical research and therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…